89Zr-Bevacizumab PET Imaging in Patients With Renal Cell Carcinoma Treated With Sunitinib or Bevacizumab Plus Interferon; a Pilot Study.

Trial Profile

89Zr-Bevacizumab PET Imaging in Patients With Renal Cell Carcinoma Treated With Sunitinib or Bevacizumab Plus Interferon; a Pilot Study.

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 01 Jan 2015

At a glance

  • Drugs Bevacizumab (Primary) ; Interferon; Sunitinib
  • Indications Renal cancer
  • Focus Biomarker; Therapeutic Use
  • Acronyms Renimage
  • Most Recent Events

    • 27 Sep 2011 Actual end date (September 2011) added as reported by ClinicalTrials.gov.
    • 27 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Feb 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top